BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 3.86%330.26M | -11.08%2.08B | -21.45%1.2B | -30.47%622.02M | -10.10%317.99M | 3.19%2.34B | 9.51%1.53B | 17.25%894.56M | 2.31%353.74M | -20.43%2.27B |
Refunds of taxes and levies | -1.74%59.53K | 164.18%666.53K | 506.73%598.03K | 7,759.65%404.51K | 73,272.44%60.58K | -49.22%252.3K | -60.49%98.56K | -97.94%5.15K | -98.52%82.57 | 152.97%496.84K |
Net deposit increase | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Net increase in borrowings from central bank | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Net increase in placements from other financial institutions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Cash received from interests, fees and commissions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Net increase in repurchase business capital | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Premiums received from original insurance contracts | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Net cash received from reinsurance business | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Net increase in deposits from policyholders | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Net increase in funds disbursed | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Net cash received from trading securities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Cash received relating to other operating activities | -21.77%15.88M | 11.39%93.8M | -14.77%54.17M | -35.60%31.26M | 25.25%20.3M | -14.80%84.21M | -6.95%63.56M | 41.09%48.54M | 327.86%16.2M | -46.35%98.83M |
Cash inflows from operating activities | 2.32%346.19M | -10.29%2.18B | -21.15%1.25B | -30.69%653.68M | -8.54%338.35M | 2.43%2.43B | 8.73%1.59B | 18.25%943.1M | 5.83%369.94M | -21.99%2.37B |
Goods services cash paid | -11.64%263.08M | -17.36%1.16B | -6.72%888.92M | -12.89%550.12M | -25.08%297.73M | -22.13%1.41B | -23.76%952.94M | -20.79%631.56M | -20.25%397.38M | -15.40%1.81B |
Staff behalf paid | 7.45%86.17M | 1.55%350.73M | 0.04%266.12M | -1.87%180.16M | -1.79%80.19M | 0.50%345.38M | 2.65%266.01M | 3.15%183.58M | 19.19%81.66M | 13.96%343.66M |
All taxes paid | -4.55%7.13M | -49.23%43.57M | -50.17%36.22M | -45.86%18.17M | -50.56%7.47M | -11.63%85.81M | -7.83%72.69M | -42.77%33.56M | -65.04%15.11M | 18.41%97.11M |
Net loan and advance increase | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Net deposit in central bank and institutions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Net lend capital | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Cash paid for fees and commissions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Cash paid for indemnity of original insurance contract | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Policy dividend cash paid | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Cash paid relating to other operating activities | -28.24%39.34M | -2.99%254.77M | -17.82%163.8M | -22.51%105M | -20.75%54.83M | -9.70%262.63M | -8.92%199.33M | 18.57%135.5M | 10.42%69.18M | 18.70%290.85M |
Cash outflows from operating activities | -10.11%395.72M | -13.76%1.81B | -9.12%1.36B | -13.29%853.45M | -21.85%440.22M | -17.24%2.1B | -17.48%1.49B | -14.28%984.21M | -16.26%563.32M | -8.17%2.54B |
Net cash flows from operating activities | 51.38%-49.53M | 11.92%367.49M | -201.66%-101.01M | -385.98%-199.77M | 47.32%-101.87M | 296.95%328.36M | 128.88%99.37M | 88.28%-41.11M | 40.15%-193.38M | -160.40%-166.72M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | --120M | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | --175M |
Cash received from returns on investments | --254.84K | ---- | --0 | --0 | --0 | ---- | --0 | --0 | --0 | --746.74K |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -38.75%245K | -64.73%400K | -58.03%400K | 58.10%400K | --400K | --1.13M | --953K | --253K | --0 | ---- |
Net cash received from disposal of subsidiaries and other business units | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
Cash received relating to other investing activities | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
Cash inflows from investing activities | 30,024.96%120.5M | -64.73%400K | -58.03%400K | 58.10%400K | --400K | -99.35%1.13M | -99.46%953K | -99.86%253K | --0 | 76,875.84%175.75M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 2,221.02%1.21M | 2,276.41%368.86M | 2,276.00%368.8M | 16.97%18.16M | -71.61%51.93K | -16.94%15.52M | 1,471.33%15.52M | 1,471.33%15.52M | -70.28%182.9K | -62.63%18.69M |
Cash paid to acquire investments | --50M | 66,566.67%100M | --0 | --0 | ---- | -99.91%150K | -99.91%150K | -99.91%150K | --0 | --175.1M |
Net cash paid to acquire subsidiaries and other business units | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
Impawned loan net increase | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
Cash paid relating to other investing activities | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
Cash outflows from investing activities | 98,497.06%51.21M | 2,891.75%468.86M | 2,253.26%368.8M | 15.85%18.16M | -71.61%51.93K | -91.91%15.67M | -91.09%15.67M | -91.09%15.67M | -99.90%182.9K | 287.59%193.79M |
Net cash flows from investing activities | 19,808.42%69.29M | -3,122.39%-468.46M | -2,402.91%-368.4M | -15.15%-17.76M | 290.30%348.07K | 19.41%-14.54M | -6,003.86%-14.72M | -6,294.14%-15.42M | 99.80%-182.9K | 63.75%-18.04M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Cash from borrowing | 896.00%199.2M | 35.11%533.31M | 30.83%503.31M | -52.69%157.54M | -92.83%20M | -10.61%394.72M | 7.35%384.72M | 55.86%333.03M | 155.82%278.89M | -13.01%441.58M |
Cash received relating to other financing activities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Cash inflows from financing activities | 896.00%199.2M | 35.11%533.31M | 30.83%503.31M | -52.69%157.54M | -92.83%20M | -10.61%394.72M | 7.35%384.72M | 55.86%333.03M | 155.82%278.89M | -13.01%441.58M |
Borrowing repayment | 141.15%280.71M | -62.26%219.13M | -48.01%194.13M | -40.77%148.57M | -8.12%116.4M | 32.25%580.7M | 15.26%373.37M | 48.69%250.85M | 28.65%126.69M | -27.53%439.08M |
Dividend interest payment | -13.74%1.17M | -7.73%96.25M | -7.26%93.76M | -6.15%86.18M | -65.26%1.36M | 4.10%104.31M | 4.56%101.09M | 1.56%91.82M | 14.41%3.91M | -4.01%100.21M |
-Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
Cash payments relating to other financing activities | --891.77K | -28.41%2.2M | 1,125,006.05%2.2M | --1.76M | ---- | -23.96%3.07M | 42.84%195.61 | --0 | --0 | 27.94%4.04M |
Cash outflows from financing activities | 140.12%282.77M | -53.85%317.58M | -38.86%290.09M | -30.98%236.51M | -9.83%117.76M | 26.64%688.08M | 12.80%474.46M | 32.25%342.67M | 28.17%130.6M | -23.84%543.33M |
Net cash flows from financing activities | 14.51%-83.57M | 173.54%215.74M | 337.61%213.23M | -719.61%-78.97M | -165.93%-97.76M | -188.31%-293.37M | -44.20%-89.74M | 78.79%-9.63M | 1,980.87%148.29M | 50.56%-101.76M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -521.23%-42.98K | 86.91%169.15K | -180.41%-630.33K | -55.89%451.03K | 101.72%10.2K | -92.00%90.5K | -53.80%783.9K | 60.90%1.02M | -803.74%-594.18K | 390.80%1.13M |
Net increase in cash and cash equivalents | 67.96%-63.85M | 459.44%114.94M | -5,866.39%-256.82M | -354.49%-296.04M | -334.51%-199.28M | 107.20%20.54M | 98.94%-4.3M | 83.54%-65.14M | 88.72%-45.86M | -1,522.75%-285.38M |
Add:Begin period cash and cash equivalents | 19.87%693.24M | 3.68%578.31M | 3.68%578.31M | 3.68%578.31M | 3.68%578.31M | -33.85%557.76M | -33.85%557.76M | -33.85%557.76M | -33.85%557.76M | 2.44%843.15M |
End period cash equivalent | 66.05%629.39M | 19.87%693.24M | -41.91%321.49M | -42.70%282.27M | -25.96%379.03M | 3.68%578.31M | 26.28%553.46M | 10.09%492.63M | 17.21%511.9M | -33.85%557.76M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.